Article Details

Why One Fund Owns 13% of This Small-Cap Pharma - Investor Ideas

Retrieved on: 2022-12-13 19:39:21

Tags for this article:

Click the tags to see associated articles and topics

Why One Fund Owns 13% of This Small-Cap Pharma - Investor Ideas. View article details on hiswai:

Excerpt

Analyst Andre Uddin with Research Capital Corporation follows the company and notes that Algernon has an "in-depth pipeline based on its novel ...

Article found on: www.investorideas.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up